Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-10-016363

Options or other derivatives

  • Director acquired 193,269 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RECTOR DAVID · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-11-17 Grant or award : show line 1 in the form Common Stock Option +43,269 $0.26 2020-11-17 43,269 495,915 D
2010-11-17 Grant or award : show line 2 in the form Common Stock Option +150,000 $0.26 2020-11-17 150,000 645,915 D
Loading xslF345X03/edgar.xml…